Download FREE Report Sample
Download Free sampleLomefloxacin is a fluoroquinolone anti-bacterial agent, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). This ingredient could inhibit bacterial DNA Rotase and have a high antibacterial activity against Enterobacteriaceae bacteria such as E.coli, S.pneumoniae, H.influenzae,S.aureus, P.aeruginosa and so on. Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well.
Lomefloxacin Market contains market size and forecasts of Lomefloxacin in global, including the following market information:
Global Lomefloxacin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lomefloxacin Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Lomefloxacin companies in 2021 (%)
The global Lomefloxacin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lomefloxacin include Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem and Sichuan North Hongguang Special Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lomefloxacin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lomefloxacin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Lomefloxacin Market Segment Percentages, by Type, 2021 (%)
Injection
Tablet
Capsule
Drops
Ointment
Global Lomefloxacin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Lomefloxacin Market Segment Percentages, by Application, 2021 (%)
External
Oral
Global Lomefloxacin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Lomefloxacin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lomefloxacin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lomefloxacin revenues share in global market, 2021 (%)
Key companies Lomefloxacin sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Lomefloxacin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Nakoda Chemicals LTD
LGM Pharma
Merck
Norna Chemical
Changzhou Sinly Pharmchem
ParChem
Sichuan North Hongguang Special Chemical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
